PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsDimethyl fumarate
Tecfidera(dimethyl fumarate)
Dimethyl, Skilarence, Tecfidera (dimethyl fumarate) is a small molecule pharmaceutical. Dimethyl fumarate was first approved as Tecfidera on 2013-03-27. It has been approved in Europe to treat multiple sclerosis, psoriasis, and relapsing-remitting multiple sclerosis.
Download report
Favorite
Top 200 Pharmaceuticals by Retail Sales
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
nervous system diseasesD009422
skin and connective tissue diseasesD017437
immune system diseasesD007154
Trade Name
FDA
EMA
Dimethylfumarate, Tecfidera (discontinued: Dimethylfumarate)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Dimethyl fumarate
Tradename
Company
Number
Date
Products
TECFIDERABiogenN-204063 RX2013-03-27
2 products, RLD, RS
Labels
FDA
EMA
Brand Name
Status
Last Update
dimethyl fumarateANDA2024-12-23
dimethyl fumarate dimethyl fumarateANDA2025-04-01
tecfideraNew Drug Application2024-03-14
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
Expiration
Code
DIMETHYL FUMARATE, TECFIDERA, BIOGEN INC
2023-02-05M-260
Patent Expiration
Patent
Expires
Flag
FDA Information
Dimethyl Fumarate, Tecfidera, Biogen Inc
109599722035-11-16U-1384
110071662035-11-16U-1384
110071672035-11-16U-1384
111298062035-11-16U-1384
112468502035-11-16U-1384
103911602035-03-13U-3148
105559932035-03-13U-3148
109940032035-03-13U-3148
83995142028-02-07U-1384
ATC Codes
L: Antineoplastic and immunomodulating agents
— L04: Immunosuppressants
— L04A: Immunosuppressants
— L04AX: Other immunosuppressants in atc
— L04AX07: Dimethyl fumarate
HCPCS
No data
Clinical
Clinical Trials
167 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Multiple sclerosisD009103EFO_0003885G352514161754
SclerosisD012598——2514121447
Relapsing-remitting multiple sclerosisD020529EFO_0003929—12129630
FlushingD005483—R23.2——11—2
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Healthy volunteers/patients———8—1——9
Chronic progressive multiple sclerosisD020528EFO_0003840——11——2
Neoplasm metastasisD009362EFO_0009708———1——1
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
ArthritisD001168EFO_0005856M05-M14—1——12
Rheumatoid arthritisD001172EFO_0000685M06.9—1———1
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
HypertensionD006973EFO_0000537I101————1
Pulmonary hypertensionD006976EFO_0001361I27.201————1
Systemic sclerodermaD012595EFO_0000717M341————1
Pulmonary arterial hypertensionD000081029——1————1
Diffuse sclerodermaD045743EFO_0000404—1————1
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Psoriatic arthritisD015535EFO_0003778L40.5————11
PsoriasisD011565EFO_0000676L40————11
LymphopeniaD008231—D72.810————11
LeukoencephalopathiesD056784—R90.82————11
Progressive multifocal leukoencephalopathyD007968EFO_0007455A81.2————11
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameDimethyl fumarate
INN—
Description
Dimethyl fumarate is an enoate ester resulting from the formal condensation of both carboxy groups of fumaric acid with methanol. Used for treatment of adults with relapsing forms of multiple sclerosis. It has a role as an immunomodulator and an antipsoriatic. It is an enoate ester, a methyl ester and a diester. It is functionally related to a methanol and a fumaric acid.
Classification
Small molecule
Drug class—
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
COC(=O)/C=C/C(=O)OC
Identifiers
PDB—
CAS-ID624-49-7
RxCUI—
ChEMBL IDCHEMBL2107333
ChEBI ID76004
PubChem CID637568
DrugBankDB08908
UNII ID—
Target
No data
Variants
No data
Financial
Revenue by drug
$
€
£
â‚£
Tecfidera – Biogen
Plot placeholder
Mock data
Subscribe for the real data
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Estimated US medical usage
Dimethyl fumarate
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 10,606 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
115,084 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use